Search

Anthony H Nguyen

Examiner (ID: 17425)

Most Active Art Unit
2854
Art Unit(s)
3307, 2854, 2853
Total Applications
2014
Issued Applications
1600
Pending Applications
48
Abandoned Applications
337

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 7103675 [patent_doc_number] => 20050106401 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-05-19 [patent_title] => 'Functionalized silicon surfaces' [patent_app_type] => utility [patent_app_number] => 11/010100 [patent_app_country] => US [patent_app_date] => 2004-12-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 4988 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0106/20050106401.pdf [firstpage_image] =>[orig_patent_app_number] => 11010100 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/010100
Functionalized silicon surfaces Dec 9, 2004 Issued
Array ( [id] => 6983266 [patent_doc_number] => 20050153336 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-07-14 [patent_title] => 'Compositions and their uses directed to nucleic acid binding proteins' [patent_app_type] => utility [patent_app_number] => 11/004127 [patent_app_country] => US [patent_app_date] => 2004-12-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28272 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0153/20050153336.pdf [firstpage_image] =>[orig_patent_app_number] => 11004127 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/004127
Compositions and their uses directed to nucleic acid binding proteins Dec 2, 2004 Abandoned
Array ( [id] => 4464472 [patent_doc_number] => 07935677 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-05-03 [patent_title] => 'Polymalic acid-based multi-functional drug delivery system' [patent_app_type] => utility [patent_app_number] => 10/580999 [patent_app_country] => US [patent_app_date] => 2004-12-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 14235 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 104 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/935/07935677.pdf [firstpage_image] =>[orig_patent_app_number] => 10580999 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/580999
Polymalic acid-based multi-functional drug delivery system Dec 2, 2004 Issued
Array ( [id] => 6959290 [patent_doc_number] => 20050215503 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-29 [patent_title] => 'HIF oligonucleotide decoy molecules' [patent_app_type] => utility [patent_app_number] => 11/003907 [patent_app_country] => US [patent_app_date] => 2004-12-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 16087 [patent_no_of_claims] => 53 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0215/20050215503.pdf [firstpage_image] =>[orig_patent_app_number] => 11003907 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/003907
HIF oligonucleotide decoy molecules Dec 1, 2004 Abandoned
Array ( [id] => 4921971 [patent_doc_number] => 20080070286 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-03-20 [patent_title] => 'Dna Participating in Hydroxylation of Macrolide Compound' [patent_app_type] => utility [patent_app_number] => 10/577655 [patent_app_country] => US [patent_app_date] => 2004-11-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19437 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0070/20080070286.pdf [firstpage_image] =>[orig_patent_app_number] => 10577655 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/577655
DNA participating in hydroxylation of macrolide compound Nov 24, 2004 Issued
Array ( [id] => 7186703 [patent_doc_number] => 20050125847 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-09 [patent_title] => 'Use of coral red fluorescence proteins as tracers for easy identification of genetic modified Baculoviruses' [patent_app_type] => utility [patent_app_number] => 10/995708 [patent_app_country] => US [patent_app_date] => 2004-11-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 3371 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0125/20050125847.pdf [firstpage_image] =>[orig_patent_app_number] => 10995708 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/995708
Use of coral red fluorescence proteins as tracers for easy identification of genetic modified Baculoviruses Nov 22, 2004 Abandoned
Array ( [id] => 5770354 [patent_doc_number] => 20050266422 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-01 [patent_title] => 'Fluoroalkoxy, nucleosides, nucleotides, and polynucleotides' [patent_app_type] => utility [patent_app_number] => 10/981966 [patent_app_country] => US [patent_app_date] => 2004-11-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 62535 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0266/20050266422.pdf [firstpage_image] =>[orig_patent_app_number] => 10981966 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/981966
Fluoroalkoxy, nucleosides, nucleotides, and polynucleotides Nov 4, 2004 Abandoned
Array ( [id] => 7097318 [patent_doc_number] => 20050129776 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-16 [patent_title] => 'Microparticles supporting cells and active substances' [patent_app_type] => utility [patent_app_number] => 10/980384 [patent_app_country] => US [patent_app_date] => 2004-11-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 7910 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0129/20050129776.pdf [firstpage_image] =>[orig_patent_app_number] => 10980384 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/980384
Microparticles supporting cells and active substances Nov 2, 2004 Abandoned
Array ( [id] => 5254061 [patent_doc_number] => 20070135517 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-06-14 [patent_title] => 'Antitumor medicine' [patent_app_type] => utility [patent_app_number] => 10/577447 [patent_app_country] => US [patent_app_date] => 2004-10-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 3224 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0135/20070135517.pdf [firstpage_image] =>[orig_patent_app_number] => 10577447 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/577447
Antitumor medicine Oct 27, 2004 Issued
Array ( [id] => 7146547 [patent_doc_number] => 20050119473 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-02 [patent_title] => 'Phosphite ester oxidation in nucleic acid array preparation' [patent_app_type] => utility [patent_app_number] => 10/974287 [patent_app_country] => US [patent_app_date] => 2004-10-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 11097 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0119/20050119473.pdf [firstpage_image] =>[orig_patent_app_number] => 10974287 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/974287
Phosphite ester oxidation in nucleic acid array preparation Oct 25, 2004 Abandoned
Array ( [id] => 5738423 [patent_doc_number] => 20060008813 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-01-12 [patent_title] => 'Compositions and methods of synthesis and use of novel nucleic acid structures' [patent_app_type] => utility [patent_app_number] => 10/966672 [patent_app_country] => US [patent_app_date] => 2004-10-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 38 [patent_figures_cnt] => 38 [patent_no_of_words] => 17942 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0008/20060008813.pdf [firstpage_image] =>[orig_patent_app_number] => 10966672 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/966672
Compositions and methods of synthesis and use of novel nucleic acid structures Oct 13, 2004 Abandoned
Array ( [id] => 6938496 [patent_doc_number] => 20050112059 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-05-26 [patent_title] => 'Enhancement of radiotherapy by an exogenous cardiac glycoside' [patent_app_type] => utility [patent_app_number] => 10/957875 [patent_app_country] => US [patent_app_date] => 2004-10-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 3307 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0112/20050112059.pdf [firstpage_image] =>[orig_patent_app_number] => 10957875 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/957875
Enhancement of radiotherapy by an exogenous cardiac glycoside Oct 3, 2004 Abandoned
Array ( [id] => 236320 [patent_doc_number] => 07595301 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-09-29 [patent_title] => 'Staple type oligonucleotide and drug comprising the same' [patent_app_type] => utility [patent_app_number] => 10/568226 [patent_app_country] => US [patent_app_date] => 2004-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 2568 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 77 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/595/07595301.pdf [firstpage_image] =>[orig_patent_app_number] => 10568226 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/568226
Staple type oligonucleotide and drug comprising the same Sep 28, 2004 Issued
Array ( [id] => 6972789 [patent_doc_number] => 20050038499 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-02-17 [patent_title] => 'Methods for coating stents with DNA and expression of recombinant genes from DNA coated stents in vivo' [patent_app_type] => utility [patent_app_number] => 10/946785 [patent_app_country] => US [patent_app_date] => 2004-09-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 3302 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0038/20050038499.pdf [firstpage_image] =>[orig_patent_app_number] => 10946785 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/946785
Methods for coating stents with DNA and expression of recombinant genes from DNA coated stents in vivo Sep 21, 2004 Abandoned
Array ( [id] => 8834333 [patent_doc_number] => 08450088 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-05-28 [patent_title] => 'Process for producing CMP-N-acetylneuraminic acid' [patent_app_type] => utility [patent_app_number] => 10/573385 [patent_app_country] => US [patent_app_date] => 2004-09-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5131 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 237 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 10573385 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/573385
Process for producing CMP-N-acetylneuraminic acid Sep 20, 2004 Issued
Array ( [id] => 13063 [patent_doc_number] => 07803397 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-09-28 [patent_title] => 'Polyethyleneglycol-modified lipid compounds and uses thereof' [patent_app_type] => utility [patent_app_number] => 10/942379 [patent_app_country] => US [patent_app_date] => 2004-09-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 24728 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/803/07803397.pdf [firstpage_image] =>[orig_patent_app_number] => 10942379 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/942379
Polyethyleneglycol-modified lipid compounds and uses thereof Sep 14, 2004 Issued
Array ( [id] => 5199163 [patent_doc_number] => 20070298481 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-12-27 [patent_title] => 'Method for Producing a Useful Intermediate in Alkaloid Biosynthesis By Using Rnai Technology' [patent_app_type] => utility [patent_app_number] => 10/572395 [patent_app_country] => US [patent_app_date] => 2004-09-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 5764 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0298/20070298481.pdf [firstpage_image] =>[orig_patent_app_number] => 10572395 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/572395
Method for Producing a Useful Intermediate in Alkaloid Biosynthesis By Using Rnai Technology Sep 14, 2004 Abandoned
Array ( [id] => 6991483 [patent_doc_number] => 20050090520 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-04-28 [patent_title] => 'Treatment of disease or injury of the nervous system with FTY720' [patent_app_type] => utility [patent_app_number] => 10/938491 [patent_app_country] => US [patent_app_date] => 2004-09-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 16973 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0090/20050090520.pdf [firstpage_image] =>[orig_patent_app_number] => 10938491 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/938491
Treatment of disease or injury of the nervous system with FTY720 Sep 9, 2004 Abandoned
Array ( [id] => 6939762 [patent_doc_number] => 20050113325 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-05-26 [patent_title] => 'Modified oligonucleotides for telomerase inhibition' [patent_app_type] => utility [patent_app_number] => 10/938184 [patent_app_country] => US [patent_app_date] => 2004-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 14202 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0113/20050113325.pdf [firstpage_image] =>[orig_patent_app_number] => 10938184 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/938184
Modified oligonucleotides for telomerase inhibition Sep 8, 2004 Issued
Array ( [id] => 4893350 [patent_doc_number] => 20080102448 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-01 [patent_title] => 'Novel Vector And Utilization Of The Same' [patent_app_type] => utility [patent_app_number] => 10/570511 [patent_app_country] => US [patent_app_date] => 2004-08-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 26852 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0102/20080102448.pdf [firstpage_image] =>[orig_patent_app_number] => 10570511 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/570511
Vector and utilization of the same Aug 30, 2004 Issued
Menu